Senseonics (NYSE:SENS) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Senseonics (NYSE:SENS) in a report published on Friday. The firm issued a sell rating on the stock.

Senseonics Stock Performance

Shares of NYSE SENS opened at $0.47 on Friday. The company has a debt-to-equity ratio of 1.79, a quick ratio of 3.70 and a current ratio of 3.96. The company has a market cap of $247.39 million, a P/E ratio of -3.33 and a beta of 0.82. The firm’s fifty day moving average is $0.43 and its two-hundred day moving average is $0.50. Senseonics has a 52-week low of $0.37 and a 52-week high of $0.97.

Senseonics (NYSE:SENS) last announced its quarterly earnings results on Monday, May 13th. The company reported ($0.03) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.03). The company had revenue of $5.05 million for the quarter, compared to the consensus estimate of $4.76 million. Senseonics had a negative net margin of 346.38% and a negative return on equity of 202.32%. As a group, analysts anticipate that Senseonics will post -0.12 EPS for the current fiscal year.

Institutional Trading of Senseonics

A number of large investors have recently made changes to their positions in the business. Price T Rowe Associates Inc. MD increased its holdings in shares of Senseonics by 16.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 367,200 shares of the company’s stock worth $196,000 after buying an additional 51,000 shares during the last quarter. RPO LLC bought a new stake in shares of Senseonics in the 4th quarter worth about $37,000. Vanguard Group Inc. increased its holdings in shares of Senseonics by 0.7% in the 1st quarter. Vanguard Group Inc. now owns 22,525,039 shares of the company’s stock worth $11,963,000 after buying an additional 155,715 shares during the last quarter. State Board of Administration of Florida Retirement System bought a new stake in shares of Senseonics in the 1st quarter worth about $91,000. Finally, Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Senseonics by 30.2% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 909,931 shares of the company’s stock worth $483,000 after buying an additional 211,128 shares during the last quarter. 12.36% of the stock is currently owned by institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.